The Urology Institute brings together the clinical expertise of Temple Health and the nationally recognized cancer research leadership of Fox Chase Cancer Center. Through this collaboration, patients have access to innovative urologic cancer clinical trials designed to improve outcomes, expand treatment options, and advance the future of urologic care.
Urologic Cancer Clinical Trials We Offer
Clinical trials through the Urology Institute focus exclusively on urologic cancers and explore new therapies, surgical techniques, and treatment approaches. Current areas of research include:
- Prostate cancer
- Bladder cancer
- Kidney cancer
- Testicular cancer
- Penile and other rare urologic cancers
These trials may offer access to treatments not yet widely available and are carefully overseen by specialized physician-researchers.
Why Fox Chase Cancer Center Leads Urologic Cancer Research
Fox Chase Cancer Center serves as Temple Health’s cancer center and is nationally recognized for its leadership in cancer research and clinical trials. As an NCI-designated Comprehensive Cancer Center, Fox Chase leads the Urology Institute’s urologic cancer research efforts, providing patients with access to rigorously designed trials supported by advanced scientific and clinical infrastructure.
This partnership allows patients of the Urology Institute to benefit from the combined strengths of an academic health system and a premier cancer research institution.
Explore Available Clinical Trials
Patients interested in learning more about urologic cancer clinical trials can explore currently enrolling studies and eligibility requirements through Fox Chase Cancer Center.
View Urologic Cancer Clinical Trials at Fox Chase Cancer Center